Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature

被引：9
|
作者：
John, Alexius [1 ,2 ]
Spain, Lavinia [2 ]
Hamid, Anis A. [1 ,2 ,3 ,4 ]
机构：
[1] Eastern Hlth, Dept Med Oncol, Melbourne, Vic 3128, Australia
[2] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic 3000, Australia
[3] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic 3128, Australia
[4] Univ Melbourne, Dept Surg, Melbourne, Vic 3010, Australia
来源：
CURRENT ONCOLOGY | 2023年 / 30卷 / 01期
关键词：
non-clear cell; renal cell carcinoma; papillary; hereditary leiomyomatosis and renal cell cancer; chromophobe; medullary; collecting duct; COMPREHENSIVE MOLECULAR CHARACTERIZATION; OPEN-LABEL; PHASE-II; SUNITINIB; CABOZANTINIB; EPIDEMIOLOGY; MULTICENTER; MONOTHERAPY; EXPRESSION; CRIZOTINIB;
D O I：
10.3390/curroncol30010070
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Non-clear cell renal cell carcinoma (nccRCC) is an entity comprised of a heterogeneous constellation of RCC subtypes. Genomic profiling has broadened our understanding of molecular pathogenic mechanisms unique to individual nccRCC subtypes. To date, clinical trials evaluating the use of immunotherapies and targeted therapies have predominantly been conducted in patients with clear cell histology. A comprehensive review of the literature has been undertaken in order to describe molecular pathogenic mechanisms pertaining to each nccRCC subtype, and concisely summarise findings from therapeutic trials conducted in the nccRCC space.
引用
收藏
页码：923 / 937
页数：15
相关论文
共 50 条
  • [1] Non-Clear Cell Renal Cell Carcinoma
    不详
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (01) : 8 - 10
  • [2] The genomic landscape of metastatic non-clear cell renal cell carcinoma.
    Carlo, Maria Isabel
    Khan, Nabeela
    Chen, Yingbei
    Hsieh, James
    Hakimi, A. Ari
    Lee, Chung-Han
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [3] Current treatment approach to non-clear cell renal carcinoma
    Timofeev, I. V.
    [J]. ONKOUROLOGIYA, 2015, 11 (04): : 24 - 33
  • [4] Metastatic non-clear cell renal cell carcinoma: current therapeutic options
    Schrader, Andres J.
    Olbert, Peter J.
    Hegele, Axel
    Varga, Zoltan
    Hofmann, Rainer
    [J]. BJU INTERNATIONAL, 2008, 101 (11) : 1343 - 1345
  • [5] Systematic Review of Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma
    Brown, Jason R.
    Calaway, Adam
    Castle, Erik
    Garcia, Jorge
    Barata, Pedro C.
    [J]. KIDNEY CANCER, 2022, 6 (01) : 53 - 68
  • [6] Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma
    Vermassen, T.
    De Meulenaere, A.
    Van de Walle, M.
    Rottey, Sylvie
    [J]. ACTA CLINICA BELGICA, 2017, 72 (01) : 12 - 18
  • [7] Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategies
    Sankin, Alexander
    Hakimi, A. Ari
    Hsieh, James J.
    Molina, Ana M.
    [J]. FRONTIERS IN ONCOLOGY, 2015, 5
  • [8] The Role of Pazopanib in Non-Clear Cell Renal Cell Carcinoma: A Systematic Review
    Sneed, Gregory T.
    Lee, Sukdong
    Brown, Jamie N.
    Hammond, Julia M.
    [J]. CLINICAL GENITOURINARY CANCER, 2019, 17 (06) : 419 - 424
  • [9] The role of immunotherapy treatment in non-clear cell renal cell carcinoma: An analysis of the literature
    Ventriglia, Jole
    Passarelli, Anna
    Pisano, Carmela
    Cecere, Sabrina Chiara
    Rossetti, Sabrina
    Feroce, Florinda
    Forte, Miriam
    Casartelli, Chiara
    Tambaro, Rosa
    Pignata, Sandro
    Perversi, Fabio
    Di Napoli, Marilena
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 188
  • [10] The role of immunotherapy in non-clear cell renal cell carcinoma
    Climent, Carla
    Soriano, Sandra
    Bonfill, Teresa
    Lopez, Natalia
    Rodriguez, Marta
    Sierra, Marina
    Andreu, Pablo
    Fragio, Monica
    Busquets, Mireia
    Carrasco, Alicia
    Cano, Ona
    Segui, Miguel-Angel
    Gallardo, Enrique
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
12345